Showing results (311-320 of 1,831) with videos related to

Sort By:
Pageof 184
ESMO Open|May 13, 2025
Novel TROP2 antibody-drug conjugates for treatment of HER2-negative metastatic breast cancer patients with brain metastases: a promising option☆J Wang, Y Zhang, R Bai, et al.
ESMO Open|May 13, 2025
A phase I/II study of the safety and efficacy of telaglenastat (CB-839) in combination with nivolumab in patients with metastatic melanoma, renal cell carcinoma, and non-small-cell lung cancerM A Gouda, M H Voss, H Tawbi, et al.
ESMO Open|May 28, 2025
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinomaR S Finn, M Kudo, P Merle, et al.
ESMO Open|May 28, 2025
Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer-final analysis from the phase II PACIFIC-6 trialM C Garassino, J Khalifa, M Reck, et al.
ESMO Open|July 15, 2025
The use of machine learning models to predict progression-free survival and overall survival outcomes from waterfall plots in randomized clinical trials (MAP-OUTCOMES)K Alshankati, A Alshibany, A Toma, et al.
ESMO Open|July 15, 2025
Exploring novel genomic biomarkers for response and survival after neoadjuvant chemotherapy and radical cystectomy of muscle-invasive bladder cancerK Holmsten, B De Laere, G Sjödahl, et al.
ESMO Open|July 27, 2025
Effectiveness of post-trastuzumab deruxtecan treatments and incidence of interstitial lung disease in HER2-positive metastatic breast cancer: a real-world, observational cohort studyK Nozawa, H Iwata, T Mukohara, et al.
ESMO Open|July 25, 2025
A comparison of the risk prediction models PERSARC and Sarculator in patients with localized soft tissue sarcoma of the extremities and trunk wallM R Kobbeltvedt, I Lobmaier, M Spreafico, et al.
ESMO Open|July 11, 2025
Quantitative risk of underlying disease conditions for progression from monoclonal gammopathy to multiple myeloma: a nationwide cohort studyH Ko, S Choi, S-S Park, et al.
ESMO Open|August 1, 2025
Neoadjuvant immunotherapy for nonmetastatic dMMR/MSI colon cancer: a real-world retrospective AGEO studyC Lemaire, A Boileve, G Manceau, et al.
Pageof 184